Investors Investors Explore Equity Investors & Analystâ Equity Investors & Analystâ Financial resultsâ Capital Market Days & other presentations Analyst Coverageâ
2013å¹´6æ6æ¥ããã¡ã¾ãã¦ãcarviewãã¨ãYahoo!èªåè»ãã¯ä¸ã¤ã«ãªãããcarview!ãã¨ãã¦ãªãã¥ã¼ã¢ã«ãããã¾ããã
ãã¼ã½ã³ã念é¡ã®ãã©ã¸ã«åèµ°è¡ã§ãã¹ããªã³ãäºé¸8çªæãçã®åªåã§FP1ããé²æ©ãããå ¨åã§ãã¤ã³ããç®æãã ãªã¼ãã¹ãã¼ãweb
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1526809698178-0');}); Feature Unlikely wins, heroic comebacks and iconic championship victories â The 10 greatest Ferrari moments as they mark 10,000 points Feature HALF TERM REPORT: Alpine â Another topsy-turvy year, but are the building blocks to stability finally in place?
Select your Disney online destination Africa South Africa Asia China Hong Kong Indonesia Japan Korea Malaysia Philippines Singapore Taiwan Thailand Australia Australia Europe Belgique ÐÑлгаÑÐ¸Ñ Äeská republika Danmark Deutschland España Îλλάδα France Italia Magyarország Nederland Norge Polska Portugal România Schweiz Suomi Sverige Türkiye United Kingdom India India Latin America Brazil Disney Latin
èµ°ãTOP èµ°ãTOP èµ°è¡ã«ã¬ã³ãã¼ èµ°è¡ã«ã¬ã³ãã¼ ã¹ãã¼ãèµ°è¡ï¼ã¬ã¼ã·ã³ã°ã³ã¼ã¹ ã¹ãã¼ãèµ°è¡ï¼ã·ã§ã¼ããµã¼ããã ã¬ã³ã¿ã«ã«ã¼ã èµ°è¡ä¼æ å ± FSWã®èµ°ãæ¹ FSWã®èµ°ãæ¹ ã¬ã³ã¿ã«è»ä¸¡ã§èµ°è¡ãããï¼ ã¹ãã¼ãèµ°è¡ãããï¼ ã¬ã¼ã¹ã«åºå ´ãããï¼ ã¬ã¼ã¹ã¨ã³ããªã¼ èµ°è¡ä¼ã«åå ãã¦ã¿ããï¼ æ°è»½ã«ã¬ã¼ã¹ã楽ãã ã³ã¼ã¹ãåãã ã¬ã¼ã¹ã®è²»ç¨ ä½é¨èµ°è¡ ä½é¨èµ°è¡/ãµã¼ãããã¿ã¯ã·ã¼/ã¬ã³ã¿ã«ã«ã¼ã ã«ã¼ã¬ã³ã¿ã«èµ°è¡ 86RACERSã«ã¼ã¬ã³ã¿ã«ã·ã¹ãã FOMULA RACERSã«ã¼ã¬ã³ã¿ã«ã·ã¹ãã CIRCUIT CHALLENGEï¼GRè»ä¸¡ã¬ã³ã¿ã«ï¼ ã¬ã³ã¿ã«ã«ã¼ã FISCOã©ã¤ã»ã³ã¹ FISCOã©ã¤ã»ã³ã¹ FISCOã©ã¤ã»ã³ã¹ç¹å ¸ æ°è¦åå¾ ãã©ã¤ãã³ã°ã¬ãã¹ã³ ãã©ã¤ãã³ã°ã¬ãã¹ã³ åå åã¬ã¼ã¹ ï¼å¯å£«ãã£ã³ä»ï¼ å¯å£«ãã£ã³ããªã³ã¬ã¼ã¹ å¯å£«ãã£ã³ã¬ãã¼ã ã¶ã»ã¯ã³ã¡ã¤ã¯ã¬ã¼
SwRI, UTSA design unique chemical process to synthesize antibiotics
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}